机译:3-吡嗪-2-基氧唑烷蛋白-2-作为新的,有效和选择性抑制剂的设计,合成和生物活性为突变族异柠檬酸脱氢酶1的新型,有效和选择性抑制剂1
Department of Pharmaceutical Engineering &
Department of Biochemical Engineering China;
Department of Pharmaceutical Engineering &
Department of Biochemical Engineering China;
German Consortium of Translational Cancer Research (DKTK) Clinical Cooperation Unit Neuropathology;
Department of Pharmaceutical Engineering &
Department of Biochemical Engineering China;
Department of Medicinal Chemistry China Pharmaceutical University;
Department of Medicinal Chemistry China Pharmaceutical University;
Department of Pharmaceutical Engineering &
Department of Biochemical Engineering China;
German Consortium of Translational Cancer Research (DKTK) Clinical Cooperation Unit Neuropathology;
Department of Pharmaceutical Engineering &
Department of Biochemical Engineering China;
Mutant IDH1; Inhibitors; D-2-HG; Allosteric; BBB;
机译:3-吡嗪-2-基氧唑烷蛋白-2-作为新的,有效和选择性抑制剂的设计,合成和生物活性为突变族异柠檬酸脱氢酶1的新型,有效和选择性抑制剂1
机译:3-(7-唑醇)-4- IndolylmaleImides作为新型突变体亚乙酸脱氢酶-1抑制剂:设计,合成和生物学评估
机译:新型2-芳基苯齐咪唑的设计与合成作为选择性突变脱氢脱氢酶2 R140Q抑制剂
机译:巯基二肽的设计与合成有效和选择性Phex抑制剂
机译:人肌苷5'-单磷酸脱氢酶抑制剂的设计,合成和生物学评估:1,5-二氮杂双环(3.1.0)己烷-2,4-二酮,作为新型的同工酶选择性癌症化学治疗剂。
机译:Scidot-42。 FT-2102 - 突变体脱氢酶的有效和选择性脑渗透抑制剂
机译:3-(吲哚-3-基)-4-(吡唑3,4-丙唑嗪-3-基-3-基)的合成与评价为有效突变族异柠檬酸脱氢酶-1抑制剂